Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis

PURPOSE: The aim of this study was to analyze clinical characteristics of skeletal metastasis in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) and treatment outcomes of continued EGFR tyrosine kinase inhibitor (TKI) therapy in patients presenting with skeletal met...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Hong, Sook-Hee, Kim, Yeon-Sil, Lee, Ji Eun, Kim, In-ho, Kim, Seung Joon, Han, Daehee, Yoo, Ie Ryung, Chung, Yang-Guk, Kim, Young-Hoon, Lee, Kyo-Young, Kang, Jin-Hyoung
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946371/
https://ncbi.nlm.nih.gov/pubmed/26790969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2015.289
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados